"Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities." by J D Hainsworth

Article

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.

Journal of Clinical Oncology (1997)

J D Hainsworth, Sarah Cannon Research Institute
J R Gray, Sarah Cannon Research Institute
S L Stroup
L A Kalman
J E Patten
L G Hopkins
M Thomas, Vanderbilt University
F A Greco

Link

Disciplines

Anesthesiology,
Physical Therapy,
Medicine and Health Sciences and
Surgery

Publication Date

January 12, 1997

DOI

10.1200/JCO.1997.15.12.3464

Citation Information

J D Hainsworth, J R Gray, S L Stroup, L A Kalman, et al.. "Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities." Journal of Clinical Oncology Vol. 15 Iss. 12 (1997) p. 3464 - 3470
Available at: http://works.bepress.com/leonard-kalman/25/